Editorial: Phosphodiesterases as Drug Targets in Airway and Inflammatory Diseases

Front Pharmacol. 2021 Apr 12:12:657596. doi: 10.3389/fphar.2021.657596. eCollection 2021.

Authors

Juraj Mokry¹, Mark Giembycz², Daniela Mokra³

Affiliations

¹ Department of Pharmacology, Jessenius Faculty of Medicine, Comenius University, Martin, Slovakia.
² Department of Physiology and Pharmacology, University of Calgary, Calgary, AB, Canada.
³ Department of Physiology, Jessenius Faculty of Medicine, Comenius University, Martin, Slovakia.

No abstract available

Keywords: Ciliary activity; PDE inhibitor; Phosphodiesterase; Respiratory disease; roflumilast.

Publication types

Editorial